Your search returned 102 results.

Results
	41.	Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal primary breast cancer patients suffering invasive ductal carcinoma. [electronic resource] by Vincze, Borbála Kapuvári, Bence Udvarhelyi, Nóra Horváth, Zsolt Mátrai, Zoltán Czeyda-Pommersheim, Ferenc Kőhalmy, Krisztina Kovács, Judit Boldizsár, Mariann Láng, István Kásler, Miklós Producer: 20150805 In: SpringerPlus vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil. [electronic resource] by Hitre, Erika Budai, Barna Adleff, Vilmos Czeglédi, Ferenc Horváth, Zsolt Gyergyay, Fruzsina Lövey, József Kovács, Tibor Orosz, Zsolt Láng, István Kásler, Miklós Kralovánszky, Judit Producer: 20051129 In: Pharmacogenetics and genomics vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. [electronic resource] by Cunningham, David Lang, Istvan Marcuello, Eugenio Lorusso, Vito Ocvirk, Janja Shin, Dong Bok Jonker, Derek Osborne, Stuart Andre, Niko Waterkamp, Daniel Saunders, Mark P Producer: 20131126 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	A Phase II, open-label, randomised study to assess the efficacy and safety of the MEK1/2 inhibitor AZD6244 (ARRY-142886) versus capecitabine monotherapy in patients with colorectal cancer who have failed one or two prior chemotherapeutic regimens. [electronic resource] by Bennouna, Jaafar Lang, Istvan Valladares-Ayerbes, Manuel Boer, Katalin Adenis, Antoine Escudero, Pilar Kim, Tae-You Pover, Gillian M Morris, Clive D Douillard, Jean-Yves Producer: 20120124 In: Investigational new drugs vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer. [electronic resource] by Martin, Miguel Bonneterre, Jacques Geyer, Charles E Ito, Yoshinori Ro, Jungsil Lang, Istvan Kim, Sung-Bae Germa, Caroline Vermette, Jennifer Wang, Kenneth Wang, Kongming Awada, Ahmad Producer: 20140121 In: European journal of cancer (Oxford, England : 1990) vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	Myasthenia in a patient with sarcoidosis and schizophrenia. [electronic resource] by Rózsa, Csilla Kis, Gábor Komoly, Sámuel Anselmo, Viktória Esik, Olga Láng, István Kas, József Németh, György Solymosi, Diana Svasztics, Egon Szentirmay, Zoltán Szobor, Albert Telekes, András Producer: 20040909 In: Ideggyogyaszati szemle vol. 57 Availability: No items available. Save to lists Add to cart (remove)
	47.	[Challenges in oncologic plastic surgery of the breast]. [electronic resource] by Mátrai, Zoltán Gulyás, Gusztáv Tóth, László Polgár, Csaba Bidlek, Mária Szabó, Eva Láng, István Horváth, Zsolt Udvarhelyi, Nóra Kunos, Csaba Sávolt, Akos Pesthy, Pál Kásler, Miklós Producer: 20110621 In: Magyar onkologia vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	48.	Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer. [electronic resource] by Rubovszky, Gábor Budai, Barna Ganofszky, Erna Horváth, Zsolt Juhos, Éva Madaras, Balázs Nagy, Tünde Szabó, Eszter Pintér, Tamás Tóth, Erika Nagy, Péter Láng, István Hitre, Erika Producer: 20180828 In: Pathology oncology research : POR vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	49.	Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. [electronic resource] by Nagahashi, Masayuki Ajioka, Yoichi Lang, Istvan Szentirmay, Zoltan Kasler, Miklos Nakadaira, Hiroto Yokoyama, Naoyuki Watanabe, Gen Nishikura, Ken Wakai, Toshifumi Shirai, Yoshio Hatakeyama, Katsuyoshi Yamamoto, Masaharu Producer: 20080430 In: World journal of gastroenterology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	50.	[Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]. [electronic resource] by Mátrai, Zoltán Tóth, László Polgár, Csaba Láng, István Gõdény, Mária Sinkovics, István Horváth, Zsolt Bidlek, Mária Udvarhelyi, Nóra Bartal, Alexandra Sávolt, Akos Ujhelyi, Mihály Kásler, Miklós Producer: 20110817 In: Magyar onkologia vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	51.	Randomized Phase III Trial of Trastuzumab Plus Capecitabine With or Without Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Who Experienced Disease Progression During or After Trastuzumab-Based Therapy. [electronic resource] by Urruticoechea, Ander Rizwanullah, Mohammed Im, Seock-Ah Ruiz, Antonio Carlos Sánchez Láng, István Tomasello, Gianluca Douthwaite, Hannah Badovinac Crnjevic, Tanja Heeson, Sarah Eng-Wong, Jennifer Muñoz, Montserrat Producer: 20170915 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	52.	Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease. [electronic resource] by Anghel, Rodica Bachmann, Alexander Bekşac, Meral Brodowicz, Thomas Finek, Jindřich Komadina, Radko Krzemieniecki, Krzysztof Lang, Istvan Marencak, Jozef von Moos, Roger Pecherstorfer, Martin Rordorf, Tamara Vrbanec, Damir Zielinski, Christoph Producer: 20140408 In: Wiener klinische Wochenschrift vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	53.	Bosutinib in combination with the aromatase inhibitor letrozole: a phase II trial in postmenopausal women evaluating first-line endocrine therapy in locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer. [electronic resource] by Moy, Beverly Neven, Patrick Lebrun, Fabienne Bellet, Meritxell Xu, Binghe Sarosiek, Tomasz Chow, Louis Goss, Paul Zacharchuk, Charles Leip, Eric Turnbull, Kathleen Bardy-Bouxin, Nathalie Duvillié, Ladan Láng, István Producer: 20150112 In: The oncologist vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	54.	Bosutinib in combination with the aromatase inhibitor exemestane: a phase II trial in postmenopausal women with previously treated locally advanced or metastatic hormone receptor-positive/HER2-negative breast cancer. [electronic resource] by Moy, Beverly Neven, Patrick Lebrun, Fabienne Bellet, Meritxell Xu, Binghe Sarosiek, Tomasz Chow, Louis Goss, Paul Zacharchuk, Charles Leip, Eric Turnbull, Kathleen Bardy-Bouxin, Nathalie Duvillié, Ladan Láng, István Producer: 20150112 In: The oncologist vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	55.	Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071). [electronic resource] by Moehler, Markus Schad, Arno Maderer, Annett Atasoy, Ajlan Mauer, Murielle E Caballero, Carmela Thomaidis, Thomas John, Jestinah M Mahachie Lang, Istvan Van Cutsem, Eric Freire, João Lutz, Manfred P Roth, Arnaud Producer: 20190729 In: Cancer chemotherapy and pharmacology vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	56.	Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial. [electronic resource] by Lang, Istvan Brodowicz, Thomas Ryvo, Larisa Kahan, Zsuzsanna Greil, Richard Beslija, Semir Stemmer, Salomon M Kaufman, Bella Zvirbule, Zanete Steger, Günther G Melichar, Bohuslav Pienkowski, Tadeusz Sirbu, Daniela Messinger, Diethelm Zielinski, Christoph Producer: 20130325 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	57.	Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. [electronic resource] by Van Cutsem, Eric Köhne, Claus-Henning Láng, István Folprecht, Gunnar Nowacki, Marek P Cascinu, Stefano Shchepotin, Igor Maurel, Joan Cunningham, David Tejpar, Sabine Schlichting, Michael Zubel, Angela Celik, Ilhan Rougier, Philippe Ciardiello, Fortunato Producer: 20110715 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	58.	Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial. [electronic resource] by von Minckwitz, Gunter Puglisi, Fabio Cortes, Javier Vrdoljak, Eduard Marschner, Norbert Zielinski, Christoph Villanueva, Cristian Romieu, Gilles Lang, István Ciruelos, Eva De Laurentiis, Michele Veyret, Corinne de Ducla, Sabine Freudensprung, Ulrich Srock, Stefanie Gligorov, Joseph Producer: 20150127 In: The Lancet. Oncology vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	59.	Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence. [electronic resource] by Chirgwin, Jacquie H Giobbie-Hurder, Anita Coates, Alan S Price, Karen N Ejlertsen, Bent Debled, Marc Gelber, Richard D Goldhirsch, Aron Smith, Ian Rabaglio, Manuela Forbes, John F Neven, Patrick Láng, István Colleoni, Marco Thürlimann, Beat Producer: 20170731 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	60.	Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. [electronic resource] by Regan, Meredith M Neven, Patrick Giobbie-Hurder, Anita Goldhirsch, Aron Ejlertsen, Bent Mauriac, Louis Forbes, John F Smith, Ian Láng, István Wardley, Andrew Rabaglio, Manuela Price, Karen N Gelber, Richard D Coates, Alan S Thürlimann, Beat Producer: 20111221 In: The Lancet. Oncology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 102 results.